SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021).
Por:
Capdevila J, Gomez M, Guillot M, Paez D, Pericay C, Safont M, Tarazona N, Vera R, Vidal J, Sastre J
Publicada:
1 abr 2022
Ahead of Print:
18 mar 2022
Resumen:
The management of localized rectal cancer requires a multidisciplinary approach to optimize outcomes, reduce morbidity and prevent under or overtreatments. While early stages may obtain benefit of local resections without any additional therapies, locally advanced rectal cancer becomes a challenge defining the better sequential strategy of surgery, radiotherapy and chemotherapy. The latest results of international phase III studies have positioned the total neoadjuvant therapy as a potential new standard of care in high risk rectal cancers, however, the best schedule is still not well defined.
Filiaciones:
Tarazona N:
Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
Department of Medical Oncology, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
hybrid, Green Published
FULL TEXT
 |
Published Version |
|
| No Accesible |
|